AbbVie Reports Positive Phase 3 Results for Alopecia Areata Drug
The second pivotal study shows upadacitinib met its primary endpoint for scalp hair regrowth in patients with severe alopecia areata.
The second pivotal study shows upadacitinib met its primary endpoint for scalp hair regrowth in patients with severe alopecia areata.
Dr Jason Hamilton discusses the increasing demand for ethnic rhinoplasty and the technical and cultural considerations that set it apart from traditional approaches.
The updated multi-panel light therapy system adds a scalp-focused mode to its existing FDA-cleared applications, offering practices a noninvasive option for patients seeking hair regrowth treatments.
Younger people are leading a shift toward small, natural-looking changes, such as baby botox and mini facelifts, says plastic surgeon.
Auto-Respond.com has released an AI-powered customer engagement platform designed to provide immediate responses on Yelp and other service lead platforms.